Helicobacter pylori chronic infection and mucosal inflammation switches the human gastric glycosylation pathways  by Magalhães, Ana et al.
Biochimica et Biophysica Acta 1852 (2015) 1928–1939
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbad isHelicobacter pylori chronic infection and mucosal inﬂammation switches
the human gastric glycosylation pathwaysAna Magalhães a,b, Ricardo Marcos-Pinto c,d,e, Alison V. Nairn f, Mitche dela Rosa f, Rui M. Ferreira a,b,
Susana Junqueira-Neto a,b, Daniela Freitas a,b, Joana Gomes a,b, Patrícia Oliveira a,b, Marta R. Santos b,
Nuno T. Marcos a,b,g, Wen Xiaogang h,i, Céu Figueiredo a,b,e, Carla Oliveira a,b,e, Mário Dinis-Ribeiro e,j,k,
Fátima Carneiro a,b,e,h, Kelley W. Moremen f, Leonor David a,b,e, Celso A. Reis a,b,d,e,⁎
a Institute for Research and Innovation in Health (i3S), University of Porto, Portugal
b Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Portugal
c Centro Hospitalar do Porto (CHP), Gastroenterology Department, Portugal
d Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Portugal
e Medical Faculty, University of Porto, Portugal
f Complex Carbohydrate Research Center and Department of Biochemistry and Molecular Biology, University of Georgia, Athens, GA, USA
g Section of Health Sciences, University of Aveiro, Portugal
h Department of Pathology, Centro Hospitalar São João, Porto, Portugal
i Centro Hospitalar Vila Nova de Gaia/Espinho, Portugal
j Gastroenterology Department, IPO Porto, Portugal
k CIDES/CINTESIS, University of Porto, PortugalAbbreviations: BabA, blood group antigen bindin
acetylglucosaminyltransferase 5; B3GALT5, β1,3-ga
fucosyltransferase 3; H. pylori, Helicobacter pylori; Lab
Sialyl-Lea/x, sialyl-Lewis a/x; SabA, sialic acid binding adh
⁎ Corresponding author at: IPATIMUP, Rua Dr. Robe
Portugal.
E-mail address: celsor@ipatimup.pt (C.A. Reis).
http://dx.doi.org/10.1016/j.bbadis.2015.07.001
0925-4439/© 2015 Elsevier B.V. All rights reserved.a b s t r a c ta r t i c l e i n f oArticle history:
Received 2 March 2015
Received in revised form 29 May 2015
Accepted 1 July 2015
Available online 2 July 2015
Keywords:
Helicobacter pylori
Chronic infection
Glycophenotype
Sialic acid-binding adhesinHelicobacter pylori exploits host glycoconjugates to colonize the gastric niche. Infection can persist for decades
promoting chronic inﬂammation, and in a subset of individuals lesions can silently progress to cancer. This
study shows that H. pylori chronic infection and gastric tissue inﬂammation result in a remodeling of the gastric
glycophenotypewith increased expression of sialyl-Lewis a/x antigens due to transcriptional up-regulation of the
B3GNT5, B3GALT5, and FUT3 genes.We observed thatH. pylori infected individuals present a marked gastric local
pro-inﬂammatory signature with signiﬁcantly higher TNF-α levels and demonstrated that TNF-induced activa-
tion of the NF-kappaB pathway results in B3GNT5 transcriptional up-regulation. Furthermore, we show that
this gastric glycosylation shift, characterized by increased sialylation patterns, favors SabA-mediated H. pylori
attachment to human inﬂamed gastric mucosa. This study provides novel clinically relevant insights into the
regulatory mechanisms underlying H. pylorimodulation of host glycosylation machinery, and phenotypic alter-
ations crucial for life-long infection. Moreover, the biosynthetic pathways here identiﬁed as responsible for
gastricmucosa increased sialylation, in response toH. pylori infection, can be exploited as drug targets for hinder-
ing bacteria adhesion and counteract the infection chronicity.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Gastric cancer is a public health burden worldwide, being the third
leading cause of cancer-related mortality. The Lauren intestinal-type
tumors constitute the most frequent form of gastric adenocarcinomas,
and commonly arise in the context of a carcinogenic pathway initiated
by chronic inﬂammation of the gastric mucosa triggered byHelicobacterg adhesin; B3GNT5, β1,3-N-
lactosyltransferase 5; FUT3,
A, LacdiNAc-speciﬁc adhesin;
esin; SNA, Sambucus nigra lectin
rto Frias s/n, 4200-465 Porto,pylori (H. pylori) infection [1]. H. pylori is classiﬁed as a carcinogenic
agent by the WHO, and epidemiological studies show that 1–3% of
infected individuals ultimately develop gastric cancer, which corre-
sponds to a million new cases every year [2].
Disease development depends on bacterial ability to establish close
contact with the gastric epithelial cells and to transfer virulence factors
[3]. One of the proteins translocated into the host cells is the cytotoxin-
associated gene A (CagA) protein, which is phosphorylated by host
kinases and interferes with key signal transduction pathways [4].
Individuals infected with cagA-positive strains present increased risk
for development of severe disease outcomes, including gastric cancer
[5,6].
Bacterial attachment is mediated by outer membrane adhesins that
bind to glycoconjugates present in the gastric mucus layer and lining
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antigen binding adhesin (BabA) recognizes ABO(H)/Lewis b blood
group antigens expressed in glycoproteins from the gastro-intestinal
tract by secretor individuals [8–10], whereas the sialic acid binding
adhesin (SabA) mediates bacterial attachment through binding to
α2,3-sialylated structures, such as sialyl-Lewis a (sialyl-Lea) and sialyl-
Lewis x (sialyl-Lex) carried by glycosphingolipids and glycoproteins
[11]. The babA gene shares regions of high homology with the babB
and babC genes. It has been demonstrated that bacteria presenting
inactive BabA can gain Lewis b binding properties by babA and babB
gene recombination [12]. Recently, a novel H. pylori adhesin has been
identiﬁed, the LacdiNAc-speciﬁc adhesin (LabA), which recognizes di-
N-acetyllactosamine (lacdiNAc) motifs, carried by MUC5AC gastric
mucin [13]. The myriad of receptors that can be exploited by H. pylori
to adhere to the gastric mucosa reﬂects the multiple target strategy
adopted by this bacterium to efﬁciently colonize the gastric niche and
maintain a chronic infection.
Glycan-mediated adhesion of H. pylori to gastric epithelial cells has
been shown to act as an important trigger for translocation of bacterial
virulence factors into the host cells [14]. The translocation of effector
molecules, such as CagA and the bacterial cell wall peptidoglycan
(PGN), results in themodulation of different host intracellular signaling
pathways, including stimulation of the NF-κB (nuclear factor κB) path-
way [15,16].
H. pylori induced inﬂammatory responses include the up-regulation
of proinﬂammatory cytokines, including IL-8 and TNF-α. Concomitantly
with the gastric mucosal inﬂammation, the human gastric glycosylation
patterns change with expression of inﬂammation associated sialylated
glycans [11,17,18]. Importantly, inﬂammation has been shown to
modulate the expression of the glycosyltransferases involved in the bio-
synthesis of terminal glycan chains [19–21]. However, little is known
about the molecular mechanisms governing the glycosylation shift
that occurs in gastric mucosa in response to infection.
We have previously shown that H. pylori induces, in human gastric
cell lines, the expression of β3GnT5, a GlcNAc-transferase that drives
the biosynthesis of the SabA-ligand sialyl-Lex [22]. However, the activa-
tion of this glycosylation pathway, as well as the existence of other
regulatory mechanisms underlying these glycophenotypic changes, in
the complex context of human H. pylori chronic infection, have never
been addressed.
To assess the effect of chronic H. pylori infection and gastric mucosa
inﬂammation on the transcriptional regulation of the enzymes that
determine the host gastric cell's glycophenotype, we have evaluated
the glycosylation and the glycosyltransferase transcriptomic proﬁle of
gastric biopsies from healthy and infected individuals. In addition, we
have determined the transcript levels of inﬂammation markers in
gastric tissues and determined the effects of TNF-α proinﬂammatory
cytokine, as well as downstream signaling pathways in the transcrip-
tional regulation of theB3GNT5 gene. Furthermore,we have determined
the functional impact of these glycophenotypic alterations on H. pylori
ability to attach to the gastric mucosa.
2. Material and methods
2.1. Human gastric tissue samples
This study includes 50 individuals, who were part of a case–control
study that encompassed ﬁrst-degree relatives of patients with early-
onset gastric carcinoma (n = 26) and controls that comprised spouses
(n = 14) and neighbors (n = 4) of the cases and dyspeptic patients
(n = 6) (Supplementary Table 1) [23]. All individuals underwent high
deﬁnition upper GI endoscopy at Centro Hospitalar do Porto (CHP,
Porto, Portugal). Parallel biopsies were collected for RNA extraction,
histopathological evaluation and H. pylori culture. Serum samples
were also collected from all individuals at the time of endoscopy. This
study was approved by the ethical committee of Centro Hospitalar doPorto (Portugal) and written informed consent was received from all
participants.
2.2. Histopathological evaluation, H. pylori infection status and
cagA genotyping
Gastric biopsy sections were stained with hematoxylin and eosin
and modiﬁed Giemsa for histological examination by two pathologists
who were blinded to the patient data and endoscopic ﬁndings. The
tissue sections were evaluated based on updated Sydney–Houston
classiﬁcation system. H. pylori was cultured from fresh biopsies and
genotyping of cagAwasperformed aspreviously described [24]. Individ-
ual serological values for anti-H. pylori IgG/IgAwere determined accord-
ing to standard protocol. Cases were classiﬁed asH. pylori positivewhen
histology and culture from fresh biopsies were positive. There were two
cases classiﬁed as H. pylori positive (based on histological observation
and high anti-H. pylori IgG/IgA antibody titers) from which bacteria
was not possible to cultivate in vitro and therefore the cagA status
could not be determined (Fig. 1A and Supplementary Table 1).
2.3. Immunohistochemistry and lectin staining
Tissue staining of sialyl-Lea (CA19.9, Santa Cruz) and sialyl-Lex
(KM93, Calbiochem) was performed as previously described [10]. The
CA19.9 antibody detects sialyl-Lea and is routinely used in the clinics.
Analysis of KM93 glycan epitope speciﬁcity showed that it is reactive
to sialyl-Lex on core 2, but does not recognizes sialyl-Lex on core 3
[25]. Additionally, binding of KM93 to the non-fucosylated type 2
sialylated structures cannot be excluded as suggested by glycan array
analysis from the Consortium for Functional Glycomics (http://www.
functionalglycomics.org).
Detection of α2,6-sialylated glycans was performed using the
SNA lectin (Sambucus nigra, Vector Laboratories) accordingly to the
procedure previously described [10]. Tissue sections from antrum biop-
sies were used whenever possible. In two cases due to the presence of
intestinal metaplasia (IM) in the antrum region, biopsies from incisura
angularis were selected. Only cytoplasmic and membrane staining of
the foveolar epithelium region was considered for expression evalua-
tion. Expression in secreted mucus and IM areas was excluded from
our analysis. Statistical analysis was performed using StatView 5.0 and
signiﬁcance determined using the Fisher's exact test.
2.4. Gastric biopsy transcriptomic analysis
Quantitative real-time PCR was performed as previously described
[26]. Brieﬂy, total RNA was isolated from frozen gastric biopsies using
the RNeasy Plus Mini RNA isolation kit (Qiagen). A cDNA reaction for
each sample was synthesized according to manufacturer's instructions
using SuperScript III (Invitrogen), including a control reaction lacking
reverse transcriptase for detection of contaminating genomic DNA. For
qRT-PCR, the cDNAwas used in triplicate reactions for each gene tested.
The sequences of the primers used in this study are included in Supple-
mentary Table 2. The relative transcript levels in each sample were
determined using the ΔΔCt method. Due to the heterogeneous nature
of the gastric biopsies, the relative transcript expression of all genes
tested was normalized to the expression of the epithelial marker
cytokeratin 18 (KRT18). Statistical analysis was performed using
GraphPad PRISM 5.0 software and signiﬁcance was evaluated by un-
paired t test with Welch's correction (95% conﬁdence interval).
2.5. Bioinformatic analysis
Using the Ensembl database [27], the nucleotide sequence cor-
responding to a CpG island (chr 3: 182970925–182972635) pre-
dicted to exist in the 5′UTR region of the human B3GNT5 gene
(ENSG00000176597) was extracted and analyzed with the software
Fig. 1. Chronic H. pylori infection of human gastric mucosa results in expression of sialylated antigens. (A) Representative micrographs of H. pylori visualized by modiﬁed Giemsa and
(B) immunohistochemical detection of sialyl-Lea and sialyl-Lex antigens in parafﬁn-embedded sections of human gastric mucosa from non-infected individuals (H. pylori−) and individ-
uals infected with either cagA-positive (H. pylori+/cagA+) or cagA-negative (H. pylori+/cagA−) strains. Magniﬁcation 200× with inserts of 400×. No major differences were observed
regarding the pattern of expression of sialylated antigens in parafﬁn and frozen sections (data not shown). (C) Graphical representation of sialyl-Lea and sialyl-Lex antigen expression
in the three biological groups, statistical signiﬁcance determined using the Fisher's exact test *p b 0.05, **p b 0.01, ***p b 0.001, and ****p b 0.0001.
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Default matrices were used and factors predicted within a dissimilarity
margin less or equal than 15%, corresponding to NF-κB [T00590] and
NF-κB1 [T00593] were selected. The same CpG island sequence was
screened for DNase I hypersensitive sites using Ensembl database [27]
and nucleotide sequence conservation across the genomes of Homo
sapiens, Pan troglodytes, Gorilla gorilla, Pongo abelii, Callithrix jacchus
andMus musculus.
2.6. Human gastric cell line culture
Human gastric carcinoma cell lineMKN45, established from a poorly
differentiated gastric adenocarcinoma (Japanese Collection of Research
Bioresources), was grown in RPMI 1640 medium with Glutamax
supplemented with 10% inactive fetal bovine serum and 1% penicillin–
streptomycin. This gastric cell line was selected based on previous
results from the group showing that this cell line is responsive to
H. pylori cagA-mediated effects [22,29] and because it is possible to
activate the NF-κB pathway in this cell line by TNF-alpha stimulation.2.7. TNF-α stimulation and NF-κB pathway inhibition assay
One day prior to treatment, MKN45 gastric cells were seeded under
standard conditions into 6-well culture plates (3× 105 cells/well) and in
8-well chamber slides (1.5 × 104 cells/well) in order to reach 70–80%
conﬂuence. Cells were treated with 40 ng/ml TNF-α (Pepro-Tech Inc.)
for 20 min, 2 h and 7 h, alone or in combination with 60 μMNF-κB acti-
vation inhibitor IV (481412, Calbiochem). As control, the same cell line
was cultured only with 60 μM NF-κB activation inhibitor IV or without
treatment, for the same time periods. For each condition tested, three
biological independent experiments were performed, each with three
replicates.2.8. Immunoﬂuorescence staining
Cells grown on 8-well chamber slides were ﬁxed with 4% parafor-
maldehyde for 15 min at room temperature, permeabilized in 0.1%
Triton X-100 in PBS for 10 min and incubated with goat non-immune
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during 2 h at room temperature with NF-κB p65 Rabbit mAb primary
antibody (D14E12 Cell Signaling) diluted 1:150 in PBS containing 5%
of BSA. Following washing with PBS, cells were incubated with Alexa
Fluor 488 goat anti-rabbit immunoglobulin (Invitrogen), diluted 1:500
in PBS with 5% of BSA for 1 h at room temperature. Cells were washed
in PBS, incubated with DAPI (Sigma) for 10 min and mounted in
VectaShield (Vector Laboratories). Images were acquired using a Zeiss
Axio cam MRm and the AxioVision Rel. 4.8 software.
2.9. B3GNT5 qRT-PCR
Total RNAwas extracted from cell lines using TRI reagent LS (Sigma-
Aldrich), according to manufacturer's protocol. RNA yield and quality
were determined spectophotometrically and 5.0 μg of total RNA
was reverse transcribed using Superscript III (Invitrogen), as de-
scribed above. Expression of B3GNT5 was quantiﬁed using Taqman
probes, acquired as pre-developed assays from Applied Biosystems
(HS00908059_m1) and normalized to the expression of the endoge-
nous control 18S (HS99999901_s1). Each sample was ampliﬁed in trip-
licate in an ABI Prism 7500 (Applied Biosystems). Relative transcript
levels were determined using the ΔΔCT-method. Statistical analysis
was performed using GraphPad PRISM 5.0 software and signiﬁcance
was evaluated with Student's T-test.
2.10. H. pylori culture
The H. pylori strains 17875/Leb and 17875babA1::kan babA2::cam
(17875babA1A2) were grown in Pylori agar (BioMérieux, Marcy
l'Étoile, France) at 37 °C under microaerobic conditions. For strain
17875babA1::kan babA2::cam, culture media included also 20 mg/L
Chloramphenicol (Sigma) and 25 mg/L Kanamycin (Sigma). The
17875/Leb strain is a spontaneous mutant that binds Leb but does not
bind to sialylated antigens [11]. Clinical isolates from patients were
cultured as previously described [30].
2.11. Immunoblot for BabA, BabB and SabA outer membrane proteins
Bacteria were collected from plates using 1 mL PBS and centrifuged
at 2400 g for 5 min; proteins were extracted with the lysis buffer RIPA
containing 1 mM PMSF, 1 mM Na3VO4, and protease inhibitor cocktail.
Protein concentration was determined using the BCA protein assay
kit and 50 μg was loaded in acrylamide gel (stacking 5%/resolving
10%) for electrophoresis. Proteins were transferred to immunoblot
polyvinylidene diﬂuoride membranes (Hybond-P PVDF Membrane,
Amersham Biosciences) at 50 V for 1 h. Membranes were blocked for
1 h in PBS-Tween containing 5% nonfat dried milk prior to incubation
overnight at 4 °C with either BabA (AK277 1:10,000), BabB (AK276
1:3000) or SabA (AK278 1:5000) antibodies [31]. Blots were incubated
with a HRP-conjugated goat anti-rabbit antibody (Santa Cruz Biotech-
nology) and ﬁnally developed with ECL (Amersham ECL Western
Blotting detection reagents).
2.12. H. pylori binding assay to human gastric mucosa
Labelingwith FITC and adhesion assayswere performed as previous-
ly described [8,10,11]. Evaluation of bacterial binding was estimated by
the number of adhered bacteria to superﬁcial foveolar epithelium
region under 200× magniﬁcation. Three independent gastric biopsies
tissue samples were considered for each biological group and at least
24 different ﬁelds from each section were quantiﬁed using the ImageJ
software. Statistical analysis was performed using GraphPad PRISM 5.0
software and signiﬁcance was evaluated by one-way ANOVA with
Dunnett's Multiple Comparison Test (95% conﬁdence interval).3. Results
3.1. H. pylori chronic infection induces the expression of alpha2,3-sialylated
antigens in human gastric mucosa
The expression of the type 1 and type 2 α2,3-sialylated antigens,
sialyl-Lea and sialyl-Lex respectively, was evaluated by tissue
immunolabeling in a series of 50 gastric biopsies that have been charac-
terized regarding gastric tissue histopathological features and genetic
characteristics of H. pylori infecting strains (Supplementary Table 1).
As represented in Fig. 1, the majority of the non-infected gastric
mucosa showed no expression of sialylated-Lewis antigens, whereas
most of the H. pylori infected individuals presented both sialyl-Lea
(85%) and sialyl-Lex (85%) staining, demonstrating that the expression
of these α2,3-sialylated structures is signiﬁcantly associated with
H. pylori infection status (p-value b 0.0001) (Fig. 1B, C, Supplementary
Table 3). The pattern of staining with CA19.9 (anti-sialyl-Lea mAb)
and KM93 (anti-sialyl-Lex mAb) was similar. Both antibodies showed
immunoreactivity in surface mucous cells as well as in few cells from
the antrum glands. Though, the extent and intensity of sialyl-Lex stain-
ing was higher, in comparison with sialyl-Lea, with strong apical label-
ing of most surface epithelial cells lining the gastric mucosa (Fig. 1B).
No differences were observed regarding the pattern of expression of
sialylated antigens in parafﬁn and frozen sections (data not shown).
Our results suggest that the expression of α2,3-sialylated-Lewis
antigens is independent of the cagA status of the infecting strain, since
individuals infected with either cagA-positive or cagA-negative strains
presented signiﬁcantly higher levels of both sialyl-Lea and sialyl-Lex
than the non-infected samples (Fig. 1B, C and Supplementary Table 3).
In addition, the expression ofα2,6-sialylated antigenswas evaluated
using the SNA lectin in a subseries of 15 biopsies including 5 controls
and 10 H. pylori infected individuals (5 cagA+ and 5 cagA−). No strong
binding of α2,6-speciﬁc SNA lectin was observed in gastric tissue from
both controls and infected individuals (Supplementary Fig. 1). A weak
positive staining was observed in rare epithelial cells of 3 H. pylori neg-
ative and 1 H. pylori infected samples. As expected, SNA positivity was
observed in inﬂammatory cells of the gastric mucosa (Supplementary
Fig. 1).
3.2. Transcriptional up-regulation of glycosyltransferase genes by H. pylori
chronic infection
To determinehowH. pylori chronic infection andmucosal inﬂamma-
tion regulate the human enzymatic pathways that deﬁne the gastric
glycophenotype, we have evaluated the transcript abundance of 19
glycosyltransferases involved in glycan biosynthesis (Fig. 2A), in gastric
biopsies from healthy and H. pylori infected individuals. This analysis
included a subseries of 24 individuals (H. pylori negative n = 8 and
H. pylori positive n=16) fromwhich frozen gastric biopsies were avail-
able (Supplementary Table 1). The transcriptional analysis was
designed to take into consideration the representation of epithelial
cells in the biopsies samples by normalization using the epithelial
marker cytokeratin 18 (KRT18).
The evaluation of the expression of the β1,3-N-
acetylglucosaminyltransferase (B3GnTs) family of genes showed
that B3GNT5 transcript expression was signiﬁcantly increased in
H. pylori infected individuals (p b 0.001), whereas the relative transcript
levels of B3GNT1, 2, 3 and 4 were similar in the two biological groups
(Fig. 2A, B).
In addition, the transcriptomic analysis of gastric biopsies showed
that H. pylori infected individuals presented signiﬁcantly higher
transcript levels of the β1,3-galactosyltransferase 5 gene (B3GALT5)
(p b 0.001), that encodes a Gal-transferase involved in the addition of
a galactose residue to nascent type 1 chains (Fig. 2A, B and C).
The terminal modiﬁcation of Lewis antigens structures is mediated
by sialyl- and fucosyltransferases (Fig. 2C). We have analyzed the
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family (ST3GalTs), and only ST3GAL5 gene showed different expression
in the two biological groups, with H. pylori infected individuals present-
ing signiﬁcantly higher transcript levels than the controls (p b 0.05)
(Fig. 2A, B).
Regarding the α1,2-(FUT2) and α1,3/4-(FUT3, FUT4, FUT6, FUT9,
FUT10 and FUT11) fucosyltransferase families, responsible for terminal
fucosylation, our analysis showed that only FUT3 expression was signif-
icantly increased in H. pylori infected individuals (p b 0.05) (Fig. 2A, B).
3.3. Gastric mucosal local transcript levels of proinﬂammatory cytokines
To assess the inﬂammatory status of the gastric mucosa samples, we
evaluated the transcript levels of proinﬂammatorymarkers described to
be induced byH. pylori infection. As expected, we observed that, despite
inter-individual variation, H. pylori infected individuals present a
markedly enhanced inﬂammatory proﬁle, with signiﬁcantly higher
transcript levels of IL-6, IL-8, TNF-α and IFN-γmolecules (Fig. 3). Impor-
tantly, and in agreement with the histology data on inﬂammation and
inﬁltration of polymorphonuclear cells, individuals in the non-infected
group presented barely detectable levels of these proinﬂammatory
molecules (Fig. 3 and Supplementary Table 1). No signiﬁcant differences
were observed for IL-1β transcript levels in the two biological groups
(Fig. 3).
3.4. Effect of TNF-α induced activation of NF-κB pathway on transcriptional
regulation of B3GNT5
The increased levels of TNF-α detected on gastric mucosa from
H. pylori infected individuals (Fig. 3) were consistent with our previous
data demonstrating that exposure of gastric epithelial cells to this proin-
ﬂammatory cytokine led to increase expression of B3GNT5 [22]. We
further investigated the involvement of NF-κB pathway on the expres-
sion of B3GNT5, as a downstream response to TNF-α activation.
In silico analysis showed that a CpG island is predicted to exist in the
5′ start of the B3GNT5 gene (chr 3: 182970925–182972635, Fig. 4A,
Ensembl v75 [27]). This sequence, putatively encompassing the
B3GNT5 promoter region [32], was shown to include several putative
binding sites for the transcription factors NF-κB and NF-κB1 (2 and 4
predicted binding sites, Fig. 4A1, 2 [28]). Moreover, such binding sites
were predicted to correspond to open chromatin areas, as pointed out
by the presence of overlapping DNase-I hypersensitive sites [27],
suggesting availability for transcription factor binding (Fig. 4A2). Addi-
tionally, most of the putative binding sites identiﬁed corresponded
to sequences highly conserved between the genomes of human and
ﬁve primates, an important indicator of biological functional relevance
(Fig. 4A5). Comparative analysis of human andmouse genomes indicat-
ed that sequence conservation was reduced, suggesting a potential for
differential regulation in distant species.
TNF-α treatment of MKN45 gastric cells resulted in nuclear translo-
cation of the p65 NF-κB subunit (Fig. 4B). The intensity of p65 nuclear
stainingwas higher at 2 and 7 h after TNF-α addition to the cells culture
medium and at these two time-points a 4-fold increase in B3GNT5 gene
expression was observed (Fig. 4C).
Concomitant treatment of MKN45 cells with TNF-α and NF-κB
activation inhibitor IV (481412) efﬁciently inhibited p65 nuclear trans-
location at the 2 and 7 h time-points (Fig. 4B). Furthermore, evaluation
of B3GNT5 transcript levels showed that NF-κB activation inhibitor IVFig. 2. Transcriptomic analysis of glycosyltransferase genes involved in biosynthesis of glycan
GalNAc-transferases, Gal-transferases, Sialyl-transferases and Fucosyl-transferases in human ga
ering all individuals within each biological group and error bars represent the standard deviation
plots represent relative gene transcript abundance for each biological group including theminim
and relative transcript abundance of the target gene was normalized to KRT18 expression level
and **p b 0.001. (C) Cartoon representation of the pathways involved in the biosynthesis of sia
ways that are shown to be induced in response to H. pylori infection are represented in red. Som
may also use as acceptors type 1/2 chains on glycoproteins (not represented in this cartoon).led to a signiﬁcant impairment of TNF-α-mediated up-regulation of
B3GNT5 transcription, and this effect was more pronounced at 7 h
post treatment with NF-κB activation inhibitor IV (Fig. 4C). The p65
nuclear staining observed at the 20 min time-point in the presence of
the inhibitor, reﬂects the lack of the required time for suppression of
NF-kappaB signaling and as expected at this time point B3GNT5
transcription levels were not reduced. MKN45 cells treated only with
NF-κB activation inhibitor IV were similar to control cells in all assays.
3.5. Gastric mucosa sialylation controls SabA-mediated H. pylori adhesion
Immunoblot analysis of H. pylori clinical isolates from chronically
infected subjects showed that most strains presented the expression
of both BabA and BabB proteins (Fig. 5A). Expression of the sialic acid
binding adhesin, SabA, wasmore heterogeneous among the clinically iso-
lated strains, with 13 out 25 strains showing very low levels or absence of
SabA protein expression. For some clinical isolates a double bandwas ob-
served, this may stem from variations in protein size. No association was
observed between SabA expression, evaluated by immunoblot analysis of
clinical isolates in in vitro cultures, and sialyl-Lea/x expression in the gastric
tissue from the corresponding subject (Fig. 5A).
In order to understand the impact of the altered glycophenotype
induced upon H. pylori infection on bacterial attachment to inﬂamed
gastric mucosa, we further evaluated the adhesion of ﬂuorescein-
labeled bacteria to gastric biopsies. We have used two previously
described model strains, the 17875babA1A2 mutant which lacks BabA
and therefore adherence is mediated by the SabA adhesin, and the
17875/Leb spontaneous mutant strain that expresses a functional
BabA adhesin but it is unable to bind sialylated structures [11]. As
shown in Fig. 5 (B and C), the 17875babA1A2 strain (SabA competent)
adhered signiﬁcantly more to the surface mucous cells and glands of
gastric mucosa from H. pylori infected individuals displaying sialylated
antigen expression (b, c), than to tissue sections from non-infected sub-
jects without sialylated antigens expression (a) (p b 0.001). In contrast,
the strain 17875/Leb (BabA competent), adhered to a similar extent to
gastric mucosa from non-infected and H. pylori infected individuals (d,
e, f), independent of the sialylation patterns of the gastric mucosa
(Fig. 5B, C). Despite lack of association between SabA expression and
mucosal expression of sialylated antigens, we observe that SabA-
mediated binding is signiﬁcantly associated with sialylated antigens
expression. These results are in agreement with previous data showing
that SabA binding is associated with sialyl-Lex expression levels and
several markers of tissue inﬂammation [11].
4. Discussion
In the present study, we demonstrate thatH. pylori chronic infection
results in a remodeling of the gastric mucosa glycosylation proﬁle, with
de novo expression of the α2,3-sialylated structures, sialyl-Lea and
sialyl-Lex. In agreement with our data, the increased expression of
α2,3-sialylated structures in response to H. pylori has been described
to occur in humans [11,17] and in different animal models of infection
[11,33–35]. Noteworthy, no alteration in α2,6-sialylated glycans [36]
was observed, when comparing infected individuals and controls,
supporting that H. pylori speciﬁcally promotes α2,3-sialylated antigens
biosynthesis.
The biosynthesis of terminal sialylated Lewis structures is depen-
dent on the coordinated activity of several glycosyltransferases.chains in human gastric mucosa. (A) qRT-PCR analysis of glycosyltransferases, including
stric biopsies. Each bar represents the mean value of relative transcript abundance consid-
. (B) qRT-PCR analysis of B3GNT5, B3GALT5, ST3GAL5 and FUT3 genes. The box andwhisker
umandmaximumvalues and themedian. qRT-PCR reactionswere performed in triplicate
s. Statistical signiﬁcance determined using unpaired t-test withWelch correction.*p b 0.05
lylated-Lewis type 1/2 chains in glycosphingolipids. The genes represented in these path-
e of the enzymes depicted in the scheme involved in terminal sialylation and fucosylation
Fig. 3. Gastric mucosal local transcript levels of inﬂammatory markers. qRT-PCR analysis of IL-1β, IL-8, IL-6, TNF-α and IFN-γ genes. The box and whisker plots represent relative gene
transcript abundance for each biological group including the minimum and maximum values and the median. qRT-PCR reactions were performed in triplicate and relative transcript
abundance of the target gene was normalized to KRT18 expression levels. Statistical signiﬁcance determined using unpaired t-test with Welch correction.*p b 0.05.
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that H. pylori is able to induce B3GNT5 expression [22]. This observa-
tion is now validated in the context of human H. pylori chronic infec-
tion by the demonstration that gastric biopsies from H. pylori
infected individuals present signiﬁcantly higher transcript levels of
B3GNT5 (Fig. 2A, B). The B3GNT5 gene encodes a glycosyltransferase
responsible for transfer aN-acetylglucosamine (GlcNAc) to galactose
(Gal), leading to the biosynthesis of lactotriaosylceramide (Lc3Cer:
GlcNAc(β1,3)Gal(β1,4)Glc-ceramide), the precursor structure of
lacto- (type 1) and neolacto-series (type 2) carbohydrate chains on
glycosphingolipids (Fig. 2C) [37,38]. Importantly, B3gnt5-deﬁcient mice,
completely lack Lc3Cer synthase activity, demonstrating that β3GnT5
expression is required for lacto/neolacto-series glycosphingolipids
biosynthesis [39]. It was also shown that sialyl-Lex biosynthesis in
human colon cancer cells is determined by Lc3Cer precursor backbone
chain biosynthesis [40,41]. In agreement, we have demonstrated
in vitro that overexpression of β3GnT5 is sufﬁcient to increase sialyl-Lex
expression [22]. Interestingly, in vitro we observed that β3GnT5 induc-
tion was associated with the H. pylori cagA status, however in the
mucosal samples such association was not observed, indicating that
within the gastricmicroenvironment, B3GNT5 transcription is not strictly
dependent on CagA injection and that in the context of chronic infection
B3GNT5 expression can be induced by the host inﬂammatory response.This observation further suggests that in vitro models of infection due
to lack of inﬂammatory context may have limitations and supports the
importance of validation using clinical samples.
In addition H. pylori infected subjects showed an up-regulation
of the B3GALT5 gene (Fig. 2A, B). Enhanced expression of β1,3-
galactosyltransferase 5 (β3GalT5) has been reported to result in
increased biosynthesis of extended type 1 chains on lactosylceramides
and glycoproteins in colon carcinoma cells [42,43], while suppression
of β3GalT5 in pancreas adenocarcinoma cells reduced the expression
of sialyl-Lea [44]. In line with these observations, the induction of
β3GalT5, in response to H. pylori infection, can drive the extension of
precursor chains towards the biosynthesis of type 1 sequences, there-
fore contributing for the increased expression of sialyl-Lea (Fig. 2C).
The transfer of sialic acid to terminal Gal on Lewis structures is
mediated by α2,3-sialyltransferases. The ST3Gal III preferentially uses
type 1 chains as acceptors leading to sialyl-Lea biosynthesis, whereas
ST3Gal IV and ST3Gal VI modify preferentially type 2 sequences to
produce sialyl-Lex [45]. No differences were observed regarding the
transcript levels of the genes encoding these enzymes in gastric
biopsies, and in H. pylori infected gastric cell lines [22], supporting the
hypothesis that it is the accumulation of type 1 and 2 lacto-series pre-
cursor chains, rather than increased sialylation that leads to increased
expression of terminal sialylated Lewis structures in response to
Fig. 4. Regulation of B3GNT5 gene expression. (A) Schematic representation of B3GNT5 gene structure (A1: white boxes for untranslated regions, gray box for protein-coding regions [27])
and predicted CpG island (A2 [27]), showing 6 putative NF-κB (in dark blue) or NF-κB1 binding sites (in light blue, A3), all of which overlapping with open chromatin areas according to
DNAse I hypersensitivity sites (in green, A4 [27]). Also displayed are the results for the NF-κB or NF-κB1 putative binding sites sequence conservation analysis across human, 5 primates
and mouse: in red, conserved nucleotides; in black, nucleotides or gaps not conserved with the human sequence (Hs for Homo sapiens, Pt for Pan troglodytes, Gg for Gorilla gorilla, Pa for
Pongo abelii, Cj for Callithrix jacchus andMm forMus musculus, A5). (B) Immunoﬂuorescence labeling for p65 (NF-κB-pathway element) in MKN45 cell line stimulated with TNF-α in the
absence or presence of NF-κB activation inhibitor IV at 20min, 2 h or 7 h time points. Cell nuclei are stained with DAPI. Magniﬁcation 630×. (C) qRT-PCR analysis of B3GNT5 gene expres-
sion inMKN45 cell line stimulated with TNF-α in the absence or presence of NF-κB activation inhibitor IV at 20min, 2 h or 7 h time points. The graph represents average value and SD of
two independent experiments performed in triplicate. Signiﬁcance was evaluated with Student's T-test. *p b 0.05 and **p b 0.001.
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regulated inH. pylori infected individuals (Fig. 2A, B). This gene encodes
a sialyltransferase, ST3Gal V, described to use almost exclusivelylactosylceramide (LacCer) as acceptor, leading to GM3 ganglioside bio-
synthesis (Fig. 2C) [45]. Although GM3 ganglioside is not involved in
H. pylori binding [46,47], it was demonstrated that GM3 has a good
Fig. 5. Impact of increased sialylation on H. pylori attachment to inﬂamed human gastric mucosa. (A) Immunoblot analysis of model H. pylori strains and clinical isolates using
BabA, BabB and SabA recognizing antibodies, and schematic representation of sialyl-Lea and sialyl-Lex expression in the corresponding individuals gastric biopsies (green: pos-
itive; red: negative). (B) Adhesion of ﬂuorescein-labeled H. pylori strain 17875babA1A2 (functional SabA+) and 17875/Leb (functional SabA−) to gastric mucosa tissue sections
from non-infected (H. pylori−) (a, d), H. pylori CagA(+) strains infected (H. pylori+/CagA+) (b, e) and H. pylori CagA(−) strains infected (H. pylori+/CagA−) (c, f) individuals,
magniﬁcation 200×. (C) Quantiﬁcation of bacterial adhesion to human gastric mucosa tissue samples, the box and whisker plots represent the minimum and maximum values
and the median of at least 24 different ﬁelds from three independent gastric biopsies for each biological group; signiﬁcance was determined by one-way ANOVA with Dunnett's
Multiple Comparison Test. ***p b 0.001.
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preventing its entrance into the gastric cells [48]. Hence, the induction
of ST3GAL5may reﬂect a host response to decrease the epithelial dam-
age associated with the infection.
Our data shows that H. pylori infected individuals also present sig-
niﬁcantly higher transcript levels of FUT3 (Fig. 2A, B), whereas no
alterations in transcript levels were observed in any of the other
fucosyltransferases. The increased expression of FUT3 is biologically rel-
evant since α1,3/4-fucosylation of sialyl-lactose and sialyl-lactosamine
is known to lead to the biosynthesis of sialyl-Lea/x (Fig. 2C) and
these structures have been demonstrated to be better receptors for
H. pylori than its precursor non-fucosylated glycan chains [49].
The up-regulation of sialyl-Lex expression in the gastrointestinal tissue,
particularly in colon, may also be attributed to decreased expression of
the B4GALNT2 glycosyltransferase, responsible for Sda antigen biosyn-
thesis [50,51]. Further evaluation of the relevance of this molecular
mechanism during gastric carcinogenesis remains to be fully addressed
[51].
There is a large collection of data supporting thatmodulation of host
glycosylation proﬁle is associated with infection and host inﬂammatoryresponse [52]. Chronic gastric inﬂammation induced by H. pylori is
characterized by the up-regulation of diverse cytokines and chemokines
[53].
The transcriptomic analysis showed that H. pylori infected individ-
uals present a local enrichment in the proinﬂammatory cytokines IL-6,
IL-8, TNF-α and IFN-γ (Fig. 3), thatwas accompanied by the recruitment
of inﬂammatory cells to the inﬂamed tissue (Supplementary Table 1).
We did not observe a signiﬁcant up-regulation of IL-1β transcript levels
(Fig. 3), in contrast with the moderate increase previously reported in
gastric mucosal samples of H. pylori infected individuals [54,55].
Based on our previous observations that TNF-α stimulation of gastric
epithelial cells resulted in increased B3GNT5 expression [22], we have
investigated the molecular mechanism underlying TNF-mediated
induction of B3GNT5. TNF-α is recognized as a potent activator of the
canonical NF-κB pathway [56]. Moreover, according to our bioinformat-
ic analysis, the predicted B3GNT5 promoter sequence presents several
highly conserved putative binding sites for NF-κB transcription factors
in open chromatin areas (Fig. 4A). Under resting conditions NF-κB com-
plexes are known to be sequestered in the cytoplasm by inhibitory IκB
proteins [56]. Upon stimulation, namely by tumor necrosis factor
1937A. Magalhães et al. / Biochimica et Biophysica Acta 1852 (2015) 1928–1939receptors family signaling upon TNF-α binding, IκB is phosphorylated
and targeted for proteosomal degradation, releasing p65-containing
heterodimers to translocate to the nucleus and stimulate the transcrip-
tion of speciﬁc genes [56]. Several reports have described activation of
the NF-κB pathway in response to H. pylori infection and inﬂammation
[57]. Additionally, we have previously shown that H. pylori infection
results in induction of several genes downstream of the NF-κB pathway
in gastric cells [22]. We demonstrated that inhibition of the NF-κB
pathway, assessed by the impairment of p65 nuclear translocation,
antagonized the effect of TNF-α on activation of B3GNT5 transcription
(Fig. 4B, C). In line with our observations, a global gene expression
analysis showed that blocking of NF-κB-mediated responses in
endothelial cells led to the down-regulation of B3GNT5 [58]. Altogether,
these data indicate that the increased expression of B3GNT5 induced
by TNF-α is mediated through activation of the NF-κB pathway
(Fig. 6).
Long-term colonization of the gastric mucosa and the establishment
of a chronic infection are dependent on balanced adaptation of both
host and H. pylori [59]. H. pylori exploits multiple glycan targets to efﬁ-
ciently colonize the gastric mucosa, taking beneﬁt of a large collection
of outer membrane proteins presenting lectin activity, namely the
BabA, LabA and SabA adhesins. Moreover, H. pylori adherence features
are known to be dynamic, allowing the bacteria to adapt to gastric
microenvironment changes, such as altered glycosylation proﬁles [11].
In our analysis, 48% of the clinical H. pylori isolates present SabA protein
expression (Fig. 5A), which is in accordance with the SabA expressionFig. 6. A model for modulation of the gastric mucosal glycophenotype during Helicobacter pyl
gastric mucosa, H. pylori adhesion to the epithelial cells is mainly mediated by BabA recognition
expressed on gastric surface epithelium. This glycan-mediated adhesion favors translocation o
secretion system (T4SS) into the host cells, leading to the activation of several intracellular sign
including IL-8 and TNF-α. We propose that during chronic infection and gastric mucosa inﬂamm
with translocation of p65 to the nucleus and activation of B3GNT5 gene transcription. Although n
bacterial products (CagA, PGN) or activation by TNF-α secreted by recruited inﬂammatory cells
type 1/2 structures in glycosphingolipids, resulting in a remodeling of the gastric epithelial c
structures, recognized by the sialic acid binding adhesin (SabA), promotes a closer membran
chronicity.frequency described on European populations [11,31,49]. Importantly,
SabA expression has been demonstrated to be subject to a dynamic
on–off switching regulated by different genetic mechanisms, including
slipped-strandmispairing (SSM) [11], a repetitive DNA element regula-
tion by a rheostat-like mechanism [60], gene duplication by gene
conversion [61], and by the acid-responsive signal (ArsRS) two compo-
nent signal transduction regulatory system [62]. This rapid switch of
SabA expression may explain the lack of association between SabA
protein expression and sialyl-Lea and sialyl-Lex tissue levels (Fig. 5A).
While the individual gastric sialylation glycome is maintained once a
chronic infection is established, the SabA expression is expected to differ
within an individual over time.
We have further evaluated the impact of increased sialylation,
observed in H. pylori chronically infected patients, on bacterial attach-
ment to gastric mucosa. Our results demonstrated that adhesion of
17875babA1A2 strain, expressing an active SabA adhesin, was signiﬁ-
cantly higher in gastric tissue samples displaying higher sialyl-Lea/x
expression (Fig. 5B, C). This higher binding potential can be attributed
to SabA-mediated binding to sialylated receptors since adhesion of a
strain lacking a functional SabA adhesin, 17875/Leb strain, showed no
differences in adhesion. SabA-mediated adhesion to inﬂamed gastric
mucosa is particularly relevant, since this adhesin binds sialylated
antigens mainly present on membrane glycosphingolipids [11], there-
fore promoting a more intimate contact between the bacteria and the
host cells for a tighter ﬁt of the infection load and efﬁcient transfer of
bacterial virulence factors (Fig. 6).ori chronic infection and implications in bacterial adhesion and pathogenesis. In healthy
of H-type 1 (H1) and Lewis b (Leb) structures present on glycoproteins (mainly mucins)
f bacterial virulence factors, such as CagA and peptidoglycan (PGN), through the type IV
aling pathways that culminate in activation of transcription of proinﬂammatory cytokines,
ation, the increased levels of TNF-α result in stimulation of the NF-κB canonical pathway,
ot depicted in this illustration, it cannot be excluded direct activation of NF-κB pathway by
. The up-regulation of β3Gnt5 activity leads to increased biosynthesis of terminal sialylated
ells glycophenotype. The increased expression of the inﬂammation-associated sialylated
e attachment of H. pylori to inﬂamed gastric mucosa, an important feature for infection
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In summary, we demonstrate, for the ﬁrst time, in human gastric
biopsies that H. pylori exploits the tightly regulated host cell glycosyla-
tion machinery inducing the expression of B3GNT5, B3GALT5 and FUT3
and leading to biosynthesis of SabA-ligands. Furthermore, we show
that up-regulation of B3GNT5, which encodes a key enzyme in
inﬂammation-driven gastric glycophenotype modulation, results from
TNF-α-mediated activation of the NF-κB pathway. Finally, our results
demonstrate that modulation of the host gastric glycosylation proﬁle
favors H. pylori chronic infection by contributing to bacterial epithelial
attachment to inﬂamed gastric mucosa.
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